This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw Turtle (+ also see Turtle/RDF Format Specification)
Oral Chemotherapy Example - Manufactured Product - Xeloda - includes a reference to a substance in ingredient element
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix sct: <http://snomed.info/id/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- <http://hl7.org/fhir/Medication/medexample015> a fhir:Medication; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "medexample015"]; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource "medexample015" </p></div><p><b>code</b>: Capecitabine 500mg oral tablet (Xeloda) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#213293)</span></p><p><b>manufacturer</b>: <a name=\"org2\"> </a></p><blockquote><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource "org2" </p></div><p><b>name</b>: Gene Inc</p></blockquote><p><b>form</b>: Tablet dose form (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#385055001)</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td>-</td><td><b>Item[x]</b></td><td><b>Strength</b></td></tr><tr><td>*</td><td><a name=\"sub04\"> </a><blockquote><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource "sub04" </p></div><p><b>code</b>: Capecitabine (substance) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#386906001)</span></p></blockquote></td><td>500 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span>/1(unit TAB from http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm)<span style=\"background: LightGoldenRodYellow\"> (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet')</span></td></tr></table><h3>Batches</h3><table class=\"grid\"><tr><td>-</td><td><b>LotNumber</b></td><td><b>ExpirationDate</b></td></tr><tr><td>*</td><td>9494788</td><td>2017-05-22</td></tr></table></div>" ]; fhir:DomainResource.contained [ a fhir:Organization; fhir:index 0; fhir:Resource.id [ fhir:value "org2" ]; fhir:Organization.name [ fhir:value "Gene Inc" ] ], [ a fhir:Substance; fhir:index 1; fhir:Resource.id [ fhir:value "sub04" ]; fhir:Substance.code [ fhir:CodeableConcept.coding [ fhir:index 0; a sct:386906001; fhir:Coding.system [ fhir:value "http://snomed.info/sct" ]; fhir:Coding.code [ fhir:value "386906001" ]; fhir:Coding.display [ fhir:value "Capecitabine (substance)" ] ] ] ]; fhir:Medication.code [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://www.nlm.nih.gov/research/umls/rxnorm" ]; fhir:Coding.code [ fhir:value "213293" ]; fhir:Coding.display [ fhir:value "Capecitabine 500mg oral tablet (Xeloda)" ] ] ]; fhir:Medication.manufacturer [ fhir:Reference.reference [ fhir:value "#org2" ] ]; fhir:Medication.form [ fhir:CodeableConcept.coding [ fhir:index 0; a sct:385055001; fhir:Coding.system [ fhir:value "http://snomed.info/sct" ]; fhir:Coding.code [ fhir:value "385055001" ]; fhir:Coding.display [ fhir:value "Tablet dose form (qualifier value)" ] ] ]; fhir:Medication.ingredient [ fhir:index 0; fhir:Medication.ingredient.itemReference [ fhir:Reference.reference [ fhir:value "#sub04" ] ]; fhir:Medication.ingredient.strength [ fhir:Ratio.numerator [ fhir:Quantity.value [ fhir:value "500"^^xsd:decimal ]; fhir:Quantity.system [ fhir:value "http://unitsofmeasure.org" ]; fhir:Quantity.code [ fhir:value "mg" ] ]; fhir:Ratio.denominator [ fhir:Quantity.value [ fhir:value "1"^^xsd:decimal ]; fhir:Quantity.system [ fhir:value "http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm" ]; fhir:Quantity.code [ fhir:value "TAB" ] ] ] ]; fhir:Medication.batch [ fhir:Medication.batch.lotNumber [ fhir:value "9494788" ]; fhir:Medication.batch.expirationDate [ fhir:value "2017-05-22"^^xsd:date ] ] . # - ontology header ------------------------------------------------------------ <http://hl7.org/fhir/Medication/medexample015.ttl> a owl:Ontology; owl:imports fhir:fhir.ttl; owl:versionIRI <http://build.fhir.org/Medication/medexample015.ttl> . # -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.